Prevention/Screening
16 - 30 of
41 Results
Sort Results:
Article:
a stronger push to offer drug therapy for primary prevention of breast cancer in higher-risk women
September 2013
Article:
New labeling will suggest STOPPING bisphosphonates (alendronate, etc) after 3 to 5 years in patients at low fracture risk
July 2013
Guideline:
American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Prevention and Treatment Of Postmenopausal Osteoporosis: 2001 Edition, with Selected Updates for 2003
December 2009
Guideline:
2010 NAMS Position Statement on the Management of Osteoporosis in Postmenopausal Women
December 2009